Clinical trial
Global Healthcare Study on Hidradenitis Suppurativa
NCT07659769 is registered in ClinicalTrials.gov with Julia Tatjana Maul as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Global Healthcare Study on Hidradenitis Suppurativa
- Lead sponsor
- Julia Tatjana Maul
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2025
- Completion date
- December 31, 2029
- Enrollment
- 9,600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hidradenitis suppurativa (acne inversa), hidradenitis suppurativa (hs)